Case Overview
Hongyu Medical
Protagonist of this issue: Joshua
Gender: younger brother
Age: 10 years old
Weight: 9.1kg
Joshua is a silver fox dog. He was diagnosed with canine valve degenerative heart disease (MMVD) four years ago. When he was first found, he only had intermittent cough without obvious other clinical symptoms. However, with the passage of time, the condition gradually worsened
Surgical overview
The diameter of valve ring before operation was 19.5mm. The lesion areas were mainly A2 and P2 areas. There were valve thickening, prolapse and flail in A2 area, and valve thickening and prolapse in P2 area. The range of lesions is very wide, with vcw of 7.8 * 5.8mm, which is an oval, moderate and severe reflux area.
After operation, there were two clipper echoes in A2 and P2 areas, vcw decreased to 2.3 * 1.9mm, Mr decreased by 70%, and reflux was significantly improved.
Preoperative MR
Postoperative MR
Postoperative Dr
Postoperative Dr
Mitral regurgitation is very common in small dogs in the elderly, with an incidence rate of 20-30%. The occurrence of the disease is related to breed, age and gender. The age of sick dogs is mostly distributed in 5 ~ 16 years old. The disease rate increases with age, mostly in small dogs and male dogs.
Canine mitral regurgitation has characteristic night cough, night asthma, weakness, exercise intolerance or fatigue after exercise and excitement, prolonged recovery time, severe purple tongue color, syncope and so on. The survival time of dogs with severe mitral regurgitation is only 3-6 months.
The control effect of traditional drugs is general, which can only alleviate symptoms, can not be cured, and the condition will still gradually worsen. The monthly drug cost ranges from 2000 to 4000 yuan. Or valve replacement. The operation is difficult, high risk, high mortality and expensive. At present, only a few teams in the world have completed individual cases, which can not be popularized in a large area.
Shanghai Hongyu medical v-clamp minimally invasive surgery has high safety, small trauma and fast recovery. It does not need cardiac arrest and cardiopulmonary bypass. It cuts a 2-3cm incision in the precordial area, punctures the heart and sends instruments to complete mitral valve repair, reduces mitral regurgitation, and provides a new technical scheme for the treatment of canine mitral regurgitation.
Canine mitral regurgitation has characteristic night cough, night asthma, weakness, exercise intolerance or fatigue after exercise and excitement, prolonged recovery time, severe purple tongue color, syncope and so on. The survival time of dogs with severe mitral regurgitation is only 3-6 months.
The control effect of traditional drugs is general, which can only alleviate symptoms, can not be cured, and the condition will still gradually worsen. The monthly drug cost ranges from 2000 to 4000 yuan. Or valve replacement. The operation is difficult, high risk, high mortality and expensive. At present, only a few teams in the world have completed individual cases, which can not be popularized in a large area.
Shanghai Hongyu medical v-clamp minimally invasive surgery has high safety, small trauma and fast recovery. It does not need cardiac arrest and cardiopulmonary bypass. It cuts a 2-3cm incision in the precordial area, punctures the heart and sends instruments to complete mitral valve repair, reduces mitral regurgitation, and provides a new technical scheme for the treatment of canine mitral regurgitation.
Hongyu Medical
